Print   Email

Press Releases

All Releases
View Summary Rockwell Medical Schedules Third Quarter 2016 Earnings Call
Nov 3, 2016
PDF 14.6 KB Add to Briefcase
View Summary Rockwell Medical to Present Data on Peritoneal Dialysis (PD) Administration of Triferic at American Society of Nephrology (ASN) Meeting November 2016
Oct 19, 2016
PDF 16.2 KB Add to Briefcase
View Summary Rockwell Medical Announces Triferic Human Intravenous (IV) Pharmacokinetic Study Published in Journal of Clinical Pharmacology
Oct 4, 2016
PDF 16.9 KB Add to Briefcase
View Summary Rockwell Medical Preparing for Calcitriol Commercial Launch
Sep 22, 2016
PDF 14.0 KB Add to Briefcase
View Summary Rockwell Medical Enters into Exclusive License Agreement with ARAM Medical to Commercialize Triferic® in Saudi Arabia, Egypt and Middle East Territories
Aug 16, 2016
PDF 17.6 KB Add to Briefcase
View Summary Rockwell Medical Reports Second Quarter Results
Aug 8, 2016
PDF 32.5 KB Add to Briefcase
View Summary Rockwell Medical Schedules Second Quarter 2016 Earnings Call
Aug 3, 2016
PDF 15.2 KB Add to Briefcase
View Summary Rockwell Medical Announces Appointment of Dr. Robin Smith to Board of Directors
Jun 23, 2016
PDF 17.7 KB Add to Briefcase
View Summary Rockwell Medical Announces Multiple International Trademark Approvals for Triferic®
May 12, 2016
PDF 15.5 KB Add to Briefcase
View Summary Rockwell Medical Reports First Quarter Results
May 10, 2016
PDF 30.1 KB Add to Briefcase
View Summary Rockwell Medical Schedules First Quarter 2016 Earnings Call
May 5, 2016
PDF 14.6 KB Add to Briefcase
View Summary Rockwell Medical Provides Update on Preparations for Calcitriol Commercial Launch
May 4, 2016
PDF 14.2 KB Add to Briefcase
View Summary Rockwell Medical Announces Triferic® Presentation "Overcoming Functional Iron Deficiency in Your Hemodialysis Patients" at the National Kidney Foundation (NKF) Spring Clinical Meeting in Boston, MA April 29, 2016
Apr 28, 2016
PDF 15.6 KB Add to Briefcase
View Summary U.S. FDA Approves Rockwell's Triferic® Powder Packet for Treating Anemia in Hemodialysis Patients
Apr 26, 2016
PDF 15.6 KB Add to Briefcase
View Summary China FDA Accepts Rockwell Medical's Triferic® Drug Submission for Commercialization in China ¬†
Mar 21, 2016
PDF 17.4 KB Add to Briefcase
View Summary Rockwell Medical Reports Fourth Quarter and Fiscal 2015 Results
Feb 29, 2016
PDF 31.5 KB Add to Briefcase
View Summary Rockwell Medical Schedules Fourth Quarter & Fiscal 2015 Earnings Call
Feb 25, 2016
PDF 14.4 KB Add to Briefcase
View Summary Rockwell Medical Files IND to Investigate Triferic for Rare Orphan Disease Iron-Refractory, Iron-Deficiency Anemia (IRIDA)
Feb 22, 2016
PDF 15.8 KB Add to Briefcase
View Summary Rockwell Medical Enters Into Exclusive License Agreement With Wanbang Biopharmaceutical Co., Ltd. to Commercialize Triferic® in China
Feb 16, 2016
PDF 15.9 KB Add to Briefcase
View Summary Rockwell Medical Announces Two Triferic® Poster Presentations Accepted for Presentation at National Kidney Foundation Spring Clinical Meetings April 27 - May 1, 2016 in Boston, MA
Jan 19, 2016
PDF 15.1 KB Add to Briefcase
Showing 21-40 of 151 Page: 1 2 3 4 ... 8  Previous 20 | Next 20
=add release to Briefcase
Stock Information
NASDAQ : RMTI
$8.52   + 0.27
Delayed at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.